Podcasts Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma mediated loss of bone strength May 07, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of the poster presentations to be held at the 2012 European Calcified Tissue Society Meeting. Comparison of Business Cases for Biosimilars and Biobetters Apr 23, 2012 Comparison of Business Cases for Biosimilars and Biobetters Evaluation of MucilAir Apr 12, 2012 Evaluation of MucilAir Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies Mar 06, 2012 Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies – SOT Poster 2012 Risk Assessment Identifying Bone as a Target Tissue in Preclinical Toxicology Studies Feb 28, 2012 Susan Smith, Senior Scientific Director and Bone Research Expert at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting. Designing Ocular Toxicology Programs Feb 13, 2012 Kelly Tenneson, Senior Research Scientist in the Ocular and Neuroscience Department at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting. Challenges in Preclinical Bioanalytical Method Development of the Deoxypridinoline Bone Resorption Biomarker in Rat Urine Feb 05, 2012 Challenges in Preclinical Bioanalytical Method Development of the Deoxypridinoline (DPD) Bone Resorption Biomarker in Rat Urine Displaying results 11-17 (of 17) |< < 1 - 2 > >|
Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma mediated loss of bone strength May 07, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of the poster presentations to be held at the 2012 European Calcified Tissue Society Meeting.
Comparison of Business Cases for Biosimilars and Biobetters Apr 23, 2012 Comparison of Business Cases for Biosimilars and Biobetters
Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies Mar 06, 2012 Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies – SOT Poster 2012
Risk Assessment Identifying Bone as a Target Tissue in Preclinical Toxicology Studies Feb 28, 2012 Susan Smith, Senior Scientific Director and Bone Research Expert at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting.
Designing Ocular Toxicology Programs Feb 13, 2012 Kelly Tenneson, Senior Research Scientist in the Ocular and Neuroscience Department at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting.
Challenges in Preclinical Bioanalytical Method Development of the Deoxypridinoline Bone Resorption Biomarker in Rat Urine Feb 05, 2012 Challenges in Preclinical Bioanalytical Method Development of the Deoxypridinoline (DPD) Bone Resorption Biomarker in Rat Urine
